Analysis of Chymosine market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Chymosine is an enzyme, which helps in protein catabolism by hydrolysis of certain covalent chemical bonds. Chymosine is found in the stomach of mammals that acquire nutrients from plant-based food by fermenting it in the abdomen through microbial actions before digestion. Chymosine is produced majorly by new-born animals in the lining of a different stomach to curdle the ingested milk.
Chymosine is also known as renin, a cheese-making enzyme. The increase in the vegan population across the globe has transformed the overall chymosine market as the extraction of chymosine from dried calf’s stomach. The global cheese making industry has been under high impact due to the prevalence of various significant changes in chymosine and its production process and source. These days, the chymosine is produced from genetically engineered microorganisms. The chymosine enables milk clotting and is majorly used in cheese production.
Don't Need a Global Report?
Save 40% on Country & Region specific reports
The increase in the vegan and flexitarian population is likely to have a positive impact on the overall chymosine market. The global chymosine market is driven by factors like the increasing demand for natural ingredients in the products. In the current market scenario, the chymosine is gaining traction, owing to the concerns of the cheese manufacturers.
The cheese manufacturers are focused on the optimization of the texture, taste, whey value and slice ability of cheese, to cater to the increasing requirements of the consumers. The new plant-based or fermented chymosine is used as a suitable coagulant to enhance the taste and texture of the cheese. There are a variety of alternatives such as animal and microbial rennet, which are available and may hamper the volume sales of chymosine in the global market.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
The global market for chymosine is segmented based on the source, form, end-use industries, sales channel and geographies. Based on the source, the global market for chymosine can be segmented into cattle, goats, camels, pigs, cats, rats and others. On the basis of form, the global chymosine market can be segmented into granules and liquid. Based on the end-use industries, the global chymosine market can be segmented into food processing industry, pharmaceutical industry, HoReCa and the household.
On the basis of sales channel, the global market for chymosine can be segmented into direct sales and indirect sales. Under indirect sales, the chymosine is sold via hypermarkets/supermarkets, wholesalers, specialty stores and online retailers. The chymosine can be segmented into seven regions: North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
The countries in South Asia and East Asia are likely to witness an increased demand for cheese for residential and commercial purpose, which is expected to boost the sales of chymosine. The rising influence of the western culture and increase in demand for fast-food in the regions is also likely to surge the overall demand for chymosine in the Asian countries.
High consumption of cheese in various food products in Europe and North America is also estimated to drive the chymosine market. Moreover, the change in the consumer preferences towards animal-free diet will also drive the market for fermented chymosine, which will eventually have a positive impact on the global market for chymosine.
The global chymosine market is most likely to expand the revenue contribution in the market significantly over the forecast period and hence makes up as an attraction for various companies to poach in different levels of the chymosine value chain. The companies engaged in the manufacturing and distribution of chymosine are focused on expanding their business footprint by investing more on research and development activities related to the production and fermentation of chymosine. The chymosine market players are planning to implement specific strategies in the future to gain a competitive edge over the other players prevailing in the market. Some of the key players operating in the global chymosine market are: Koninklijke DSM N. V., Hansen A/S, Nelson Jameson, Sigma-Aldrich, Mayasan AS, Apex Biotechnol, Alinda Velco and Maysa GIDA, among others.
The research report presents a comprehensive assessment of the Chymosine market and contains thoughtful insights, facts, historical data and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to Chymosine market segments such as source, form, end-use industries, sales channel and geographies.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments of Chymosine. The report also maps the qualitative impact of various market factors on market segments and geographies.
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunitiesPre Book
Get A Special pricing for start-ups and universitiesEnquiry Before Buying
- Humble, Yet Honored -
- Research Methodology -
An Adaptive Approach to Modern-day Research NeedsGet Methodology
Rising inclination towards veganism is boosting the global chymosine market.
At present, Europe accounts for a leading share of the global chymosine market.
Worldwide demand for chymosine is predicted to increase at a CAGR of 5% through 2028.
Need An Exclusive Report For Your Unique Requirement?